Free Trial

CG Oncology (CGON) Earnings Date, Estimates & Call Transcripts

CG Oncology logo
$27.42 -0.06 (-0.21%)
As of 09:40 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

CG Oncology Earnings Summary

CG Oncology posted Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.45, which missed the consensus estimate of -$0.36 by $0.09. Quarterly revenue was reported to be $0.05 million, below the consensus estimate of $0.53 million. With a trailing EPS of -$1.51, CG Oncology's earnings are expected to decrease next year, from ($1.31) to ($1.77) per share.

Upcoming Q2
Earnings Date
Aug. 14Before Market OpensEstimated
Consensus EPS
(May. 13)
-$0.36
Actual EPS
(May. 13)
-$0.45 Missed By -$0.09
Actual Revenue
(May. 13)
$0.05M

Q1 2025 Earnings Resources

CGON Upcoming Earnings

CG Oncology's next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules.

Get CG Oncology Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CG Oncology and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CGON Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CGON Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CG Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.58-$0.49-$0.54
Q2 20252-$0.56-$0.52-$0.54
Q3 20252-$0.58-$0.54-$0.56
Q4 20252-$0.60-$0.57-$0.59
FY 2025 8 -$2.32 -$2.12 -$2.22
Q1 20261-$0.60-$0.60-$0.60
Q2 20261-$0.63-$0.63-$0.63

CG Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025
(Estimated)
--------
5/13/2025Q1 2025-$0.36-$0.45 -$0.09-$0.45$0.53M$0.05M
3/25/2025Q4 2024-$0.37-$0.48 -$0.11-$0.48$0.11M$0.46M
11/12/2024Q3 2024-$0.36-$0.30+$0.06-$0.30$0.30M$0.04M
8/8/2024--$0.42-$0.28+$0.14-$0.28-$0.11M
5/9/2024Q1 2024-$0.35-$0.36 -$0.01-$0.36-$0.53M

CG Oncology Earnings - Frequently Asked Questions

CG Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on CGON's earnings history.

In the previous quarter, CG Oncology (NASDAQ:CGON) missed the analysts' consensus estimate of ($0.36) by $0.09 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. CGON's actual earnings.

CG Oncology (NASDAQ:CGON) has a recorded annual revenue of $662,000.00.

CG Oncology (NASDAQ:CGON) has a recorded net income of -$48.61 million. CGON has generated -$1.51 earnings per share over the last four quarters.

CG Oncology's earnings are expected to decrease from ($1.31) per share to ($1.77) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:CGON) was last updated on 6/11/2025 by MarketBeat.com Staff
From Our Partners